소변 배액 주머니 : 시장 점유율 분석, 업계 동향 및 통계, 성장 예측(2026-2031년)

According to Mordor Intelligence, the urinary drainage bags market size is expected to increase from USD 2.12 billion in 2025 to USD 2.22 billion in 2026 and reach USD 2.79 billion by 2031, growing at a CAGR of 4.69% over 2026-2031.

This report is Segmented by Product Type (Large Bags and Leg Bags), Usage Type (Reusable, and Disposable), Capacity (0-500 Ml, 500-1000 Ml, 1000-2000 Ml), End User (Hospitals, Clinics, Home Healthcare, Ambulatory Surgical Centers, Others), and Geography (North America, Europe, Asia-Pacific, Middle East and Africa, South America). The Market Forecasts are Provided in Terms of Value (USD).

Global Urinary Drainage Bags Market Trends and Insights

Rising Burden Of Urinary Incontinence and Retention

Urinary incontinence and urinary retention remain key demand drivers for the urinary drainage bags market. The World Health Organization identifies incontinence as a core geriatric syndrome that often occurs alongside frailty, limited mobility, and cognitive decline, keeping it central to care planning for older adults. In Europe, the condition affects 25% to 45% of women and up to 40% of the broader population. Its economic burden was estimated at EUR 69.2 billion (USD 79.08 billion) in 2023 and is projected to reach EUR 86.7 billion (USD 99.08 billion) by 2030. Demand is rising faster among people aged 80 years and older, the fastest-growing group in several mature healthcare systems, while improved screening and care pathways continue to expand the treated patient base.

Growth In Postoperative Urinary Management Needs

Postoperative urinary retention continues to support the urinary drainage bags market, as catheterization remains a common practice after many procedures. A 2025 study in the Journal of the American Academy of Orthopaedic Surgeons reports that postoperative urinary retention can affect up to 43% of orthopedic surgery patients, keeping drainage bag use closely linked to perioperative care. In the United States, published research states that nearly 30 million indwelling urethral catheters are placed each year across medical and surgical settings, with most placements tied to hospital-based care. As elective procedures recover and expand, the market continues to benefit from steady demand for catheter-associated drainage products, with clinical protocols shifting preference toward anti-reflux and infection-resistant systems for sensitive postsurgical periods.

Infection Risk, Leakage Anxiety, and User Non-Compliance

The urinary drainage bags market faces constraints from infection concerns, leakage anxiety, odor issues, and the social burden of visible catheter use, which can reduce acceptance and lead to early discontinuation. The World Health Organization's ICOPE guidance recommends absorbent products as the first containment option when catheterization is not clinically required, limiting broader use in community and long-term care settings. In home settings, poor handling practices, such as incorrect bag positioning, irregular emptying, or improper reconnection, can reduce the perceived benefits of higher-quality systems. This restraint is more evident in lower-resource settings, where limited patient education and follow-up support continue to affect adoption and pricing in the urinary drainage bags market.

Other drivers and restraints analyzed in the detailed report include:

1. Expanding Home-Based Continence Care Pathways
2. Infection-Control Upgrades, Latex-Free and Anti-Reflux
3. Hospital Budget Compression and Tender-Driven Pricing

For complete list of drivers and restraints, kindly check the Table Of Contents.

Segment Analysis

Leg bags are expected to account for 57.60% of revenue in 2025, giving them the leading position in the urinary drainage bags market. Their share reflects a steady shift toward ambulatory-compatible formats that better support daily mobility and home care use. Patients and caregivers value their compact design, adjustable fixation, and discreet wear, which make leg bags easier to use outside hospital settings. This format also supports a wider pricing ladder than large bedside bags, as it includes basic home-use products as well as premium silicone and anti-reflux variants. This broader product mix creates a stronger value opportunity for the urinary drainage bags market than standardized inpatient bags.

Disposable urinary drainage bags are projected to register a 4.90% CAGR from 2026 to 2031, making them the faster-growing usage format in the urinary drainage bags market. Disposable bags are expected to represent 59.55% of revenue in 2025, while reusable alternatives remain relevant mainly in home care settings where cost control matters and users can manage manual cleaning more consistently. Infection-control expectations, rather than simple affordability, shape the difference between the two formats. APIC guidance states that the drainage system should remain a sterile closed circuit, and any disconnection is considered a break in prevention practice, supporting wider disposable use in acute care. As a result, hospital procurement is steadily shifting toward single-use systems in the urinary drainage bags market.

Complete Report Scope:

• By Product Type
  • Large Bags
  • Leg Bags
• By Usage Type
  • Reusable Urinary Drainage Bags
  • Disposable Urinary Drainage Bags
• By Capacity
  • 0-500 Ml
  • 500-1000 Ml
  • 1000-2000 Ml
• By End User
  • Hospitals
  • Clinics
  • Home Healthcare
  • Ambulatory Surgical Centers
  • Others
• By Geography
  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • Germany
    • United Kingdom
    • France
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • Rest of Asia-Pacific
  • Middle East and Africa
    • GCC
    • South Africa
    • Rest of Middle East and Africa
  • South America
    • Brazil
    • Argentina
    • Rest of South America

Geography Analysis

North America accounted for 39.95% of revenue in 2025, making it the largest regional segment in the urinary drainage bags market. The United States remains the primary demand center, supported by high catheter use across hospital, surgical, and home-based care settings. Nearly 30 million indwelling urethral catheters are placed each year in the country across medical and surgical settings, creating a large recurring base for drainage products. Canada adds stable demand through an aging population and broad healthcare coverage, while Mexico benefits from expanding private hospital capacity and rising continence care awareness.

Europe remains a large and structurally important region in the urinary drainage bags market, with Germany, the United Kingdom, and France supporting the largest regional demand pools. The prevalence burden remains substantial, with a broad base of continence-related needs that continues to increase with age. Germany remains especially important, as an aging population and strong specialist access support the continued use of advanced catheter and drainage solutions. In parts of Western Europe, preference is shifting toward silicone-based formats for longer dwell times, while Italy, Spain, and the rest of Europe remain more price sensitive.

Asia-Pacific is projected to grow at a CAGR of 5.34% from 2026 to 2031, making it the fastest-growing geography in the urinary drainage bags market. The region's rapidly expanding elderly population and growing focus on integrated care for older adults continue to support demand. China is expanding hospital and urological care capacity, Japan has a mature home care base, and India and South Korea are adding demand through healthcare expansion and demographic change. South America is benefiting from infrastructure investment, led by Brazil and Argentina, while the Middle East and Africa remain earlier-stage markets driven mainly by hospital expansion in the Gulf and gradual home care adoption in South Africa.

1. Amsino International, Inc.
2. B. Braun
3. Beckton Dickinson
4. Cardinal Health
5. Coloplast
6. Convatec
7. Cook Group
8. Flexicare Medical
9. GPC Medical Ltd.
10. Hollister
11. Manfred Sauer GmbH
12. Mckesson
13. Medline Industries
14. Medtronic
15. Romsons Scientific and Surgical Industries Pvt. Ltd.
16. Santex S.p.A.
17. Sol-Millennium Medical Group, Inc.
18. Teleflex
19. Utah Medical Products
20. Well Lead Medical Co., Ltd.

Additional Benefits:

• The market estimate (ME) sheet in Excel format
• 3 months of analyst support

TABLE OF CONTENTS

1 INTRODUCTION

• 1.1 Study Assumptions and Market Definition
• 1.2 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET LANDSCAPE

• 4.1 Market Overview
• 4.2 Market Drivers
  • 4.2.1 Rising Burden of Urinary Incontinence and Retention
  • 4.2.2 Growth In Postoperative Urinary Management Needs
  • 4.2.3 Expanding Home-Based Continence Care Pathways
  • 4.2.4 Infection-Control Upgrades, Latex-Free and Anti-Reflux Designs
  • 4.2.5 Reimbursement Pressure Favoring Standardized Low-Cost Drainage Systems
  • 4.2.6 Under-Recognized Demand from Long-Stay Mobility-Limited Patients Using Wearable Leg Bags
• 4.3 Market Restraints
  • 4.3.1 Infection Risk, Leakage Anxiety, and User Non-Compliance
  • 4.3.2 Hospital Budget Compression and Tender-Driven Pricing
  • 4.3.3 Disposal, Odor, and Biomedical Waste Handling Burdens
  • 4.3.4 Substitution Risk from Intermittent Catheterization and Alternative Bladder Management
• 4.4 Value/Supply Chain Analysis
• 4.5 Regulatory Landscape
• 4.6 Technological Outlook
• 4.7 Porter's Five Forces Analysis
  • 4.7.1 Threat of New Entrants
  • 4.7.2 Bargaining Power of Suppliers
  • 4.7.3 Bargaining Power of Buyers
  • 4.7.4 Threat of Substitutes
  • 4.7.5 Intensity of Competitive Rivalry

5 MARKET SIZE AND GROWTH FORECASTS (VALUE, USD)

• 5.1 By Product Type
  • 5.1.1 Large Bags
  • 5.1.2 Leg Bags
• 5.2 By Usage Type
  • 5.2.1 Reusable Urinary Drainage Bags
  • 5.2.2 Disposable Urinary Drainage Bags
• 5.3 By Capacity
  • 5.3.1 0-500 Ml
  • 5.3.2 500-1000 Ml
  • 5.3.3 1000-2000 Ml
• 5.4 By End User
  • 5.4.1 Hospitals
  • 5.4.2 Clinics
  • 5.4.3 Home Healthcare
  • 5.4.4 Ambulatory Surgical Centers
  • 5.4.5 Others
• 5.5 By Geography
  • 5.5.1 North America
    • 5.5.1.1 United States
    • 5.5.1.2 Canada
    • 5.5.1.3 Mexico
  • 5.5.2 Europe
    • 5.5.2.1 Germany
    • 5.5.2.2 United Kingdom
    • 5.5.2.3 France
    • 5.5.2.4 Italy
    • 5.5.2.5 Spain
    • 5.5.2.6 Rest of Europe
  • 5.5.3 Asia-Pacific
    • 5.5.3.1 China
    • 5.5.3.2 India
    • 5.5.3.3 Japan
    • 5.5.3.4 Australia
    • 5.5.3.5 South Korea
    • 5.5.3.6 Rest of Asia-Pacific
  • 5.5.4 Middle East and Africa
    • 5.5.4.1 GCC
    • 5.5.4.2 South Africa
    • 5.5.4.3 Rest of Middle East and Africa
  • 5.5.5 South America
    • 5.5.5.1 Brazil
    • 5.5.5.2 Argentina
    • 5.5.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

• 6.1 Market Concentration
• 6.2 Market Share Analysis
• 6.3 Company Profiles (includes Global Level Overview, Market Level Overview, Core Segments, Financials as available, Strategic Information, Market Rank/Share, Products and Services, Recent Developments)
  • 6.3.1 Amsino International, Inc.
  • 6.3.2 B. Braun SE
  • 6.3.3 Becton, Dickinson and Company
  • 6.3.4 Cardinal Health, Inc.
  • 6.3.5 Coloplast A/S
  • 6.3.6 ConvaTec Group Plc
  • 6.3.7 Cook Medical LLC
  • 6.3.8 Flexicare Medical Limited
  • 6.3.9 GPC Medical Ltd.
  • 6.3.10 Hollister Incorporated
  • 6.3.11 Manfred Sauer GmbH
  • 6.3.12 McKesson Corporation
  • 6.3.13 Medline Industries, LP
  • 6.3.14 Medtronic plc
  • 6.3.15 Romsons Scientific and Surgical Industries Pvt. Ltd.
  • 6.3.16 Santex S.p.A.
  • 6.3.17 Sol-Millennium Medical Group, Inc.
  • 6.3.18 Teleflex Incorporated
  • 6.3.19 Utah Medical Products, Inc.
  • 6.3.20 Well Lead Medical Co., Ltd.

7 MARKET OPPORTUNITIES AND FUTURE OUTLOOK

• 7.1 White-Space and Unmet-Need Assessment